Survival in Systemic Sclerosis-Pulmonary Arterial Hypertension by Serum Autoantibody Status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry

অনুরূপ উপাদানগুলি

• Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS)
  অনুযায়ী: Kolstad, Kathleen D., অন্যান্য
  প্রকাশিত: (2018)
• Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): Baseline Characteristics and Description of Study Population
  অনুযায়ী: Hinchcliff, Monique, অন্যান্য
  প্রকাশিত: (2011)
• Baseline Characteristics and Follow up in Patients with Normal Hemodynamics vs. Borderline Mean Pulmonary Arterial Pressure in Systemic Sclerosis — Results from the PHAROS Registry
  অনুযায়ী: Bae, Sangmee, অন্যান্য
  প্রকাশিত: (2012)
• Changes in hemodynamic classification over time are common in systemic sclerosis-associated pulmonary hypertension: insights from the PHAROS cohort
  অনুযায়ী: Lammi, Matthew R., অন্যান্য
  প্রকাশিত: (2018)
• Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort
  অনুযায়ী: Lammi, Matthew R., অন্যান্য
  প্রকাশিত: (2017)